Cargando…
In silico Therapeutics for Neurogenic Hypertension and Vasovagal Syncope
Neurocardiovascular diseases (NCVD) are the leading cause of death in the developed world and will remain so till 2020. In these diseases the pathologically changed nervous control of cardiovascular system has the central role. The actual NCV syndromes are neurogenic hypertension, representing the s...
Autores principales: | Bojić, Tijana, Perović, Vladimir R., Glišić, Sanja |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4720751/ https://www.ncbi.nlm.nih.gov/pubmed/26834545 http://dx.doi.org/10.3389/fnins.2015.00520 |
Ejemplares similares
-
“Complex” Vasovagal Syncope: A Zebra Among Horses
por: Siddiqi, Anwer Zohaib, et al.
Publicado: (2020) -
In Silico Screening of Natural Compounds for Candidates 5HT6 Receptor Antagonists against Alzheimer’s Disease
por: Bojić, Tijana, et al.
Publicado: (2022) -
Differential Diagnostic Models Between Vasovagal Syncope and Psychogenic Pseudosyncope in Children
por: Zhang, Zhening, et al.
Publicado: (2020) -
Pacing for Vasovagal Syncope
por: Wijesekera, Nevin T, et al.
Publicado: (2002) -
Identification of Candidate Allosteric Modulators of the M1 Muscarinic Acetylcholine Receptor Which May Improve Vagus Nerve Stimulation in Chronic Tinnitus
por: Bojić, Tijana, et al.
Publicado: (2017)